3-allyl-5,7-dimethylbenzo[d]thiazol-2(3H)-imine hydrobromide, 95.0%, 1g

2-Chloro-5-nitro-1,3-benzothiazole, 97.0%, 1g

Antimony(III) oxide, min. 99%, pa, 100 g, plastic packaging.

2-(9-(PYRIDIN-2-YL)-6-OXASPIRO[4.5]DECAN-9-YL)ETHANAMINE, 95.0%, 250mg

3-Bromo-5-fluoroisonicotinamide, 95.0%, 5g

(S)-(-)-t-Butylsulfinamide, 98.0%, 100g

Benzyl (3s,4s)-4-amino-3-hydroxypiperidine-1-carboxylate, 98+%, 5g

5-Bromo-N-(3,5-dimethoxybenzyl)-2,4-difluoro-N-(5-fluorothiazol-2-yl)benzenesulfonamide, 95%, 250mg

4-amino-3-(3-chlorophenyl)-4,5-dihydro-1H-1,2,4-triazole-5-thione, 97%, 50mg

7-Nitro-3,4-dihydro-2H-1,4-benzoxazine, 95.0%, 250mg

tert-Butyl 4-aminopicolinate, 95.0%, 100mg

4-Bromobutan-1-amine hydrobromide, 96.00%, 25g

6-IODO-2,3-DIMETHOXYPYRIDINE, 97.0%, 100mg